Search results
Results from the WOW.Com Content Network
Eli Lilly And Co (NYSE:LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on February 6. As per data from Benzinga Pro, the Wall Street estimates sales of $13 ...
Eli Lilly (NYSE: LLY) Q4 2024 Earnings Call Feb 06 ... Before you buy stock in Eli Lilly, consider this: ... Realized prices decreased 5% in the U.S. due to favorable changes to estimate for ...
But revenue from Zepbound missed analyst estimates of $1.7 billion, with Lilly reporting nearly $1.3 billion. Eli Lilly said US sales of the two drugs were "negatively impacted by inventory ...
Eli Lilly reported fourth quarter and full-year earnings for 2024 on Thursday.The results largely beat Wall Street estimates and sent the stock up about 2%. But the company missed on GLP-1 sales. ...
The stock price is now down about 10% on the year as of this writing. ... Zscaler trades at a forward price-to-sales multiple of about 9.6 based on current fiscal-year analyst estimates. Given its ...
Eli Lilly is a stock which you might consider to be "priced to perfection" because of how expensive it is. Prior to this recent sell-off, it was trading at well over 100 times its trailing earnings.
According to data compiled by S&P Global Market Intelligence, Zscaler's stock was down by almost 19% week to date as of late Thursday evening. An uninspiring quarterly earnings report, accompanied ...
Eli Lilly's (LLY) Q3 earnings beat estimates while sales miss. Shares drop in pre-market trading.